<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[pharming Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/pharming.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to pharming]]></description>
	<s:counts start="0" returned="20" found="21" />
	<language>en-us</language>
	<item>
		<title><![CDATA[FDA authorizes investigational new drug application for recombinant human C1 inhibitor in kidney transplantation]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200809/ai_n28054142]]></link>
		<description><![CDATA[Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) announced today that the US Food and Drug Administration FDA has authorized a clinical study with recombinant human C1 inhibitor (rhC1INH) for the treatment of antibody-mediated rejection AMR in kidney transplantation. Dr. Hans Sollinger of the University of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 03 Sep 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/amr+research.html"><![CDATA[AMR Research]]></category>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://resources.bnet.com/topic/rejection.html"><![CDATA[rejection]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[PHARMING RECEIVES ORPHAN DRUG DESIGNATION FOR RECOMBINANT FIBRINOGEN FROM FDA]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200710/ai_n21046388]]></link>
		<description><![CDATA[PHARMACEUTICAL DEVELOPMENT For FiBRINOGEN DEFICIENCIEs Initiated ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 11 Oct 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Pharming to Present at UBS Global Life Sciences Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200709/ai_n19525203]]></link>
		<description><![CDATA[Biotech company Pharming Group NV ("Pharming") (Euronext: PHARM) today announced that Pharming will present at the UBS Global Life Sciences (September 24-27,  2007) in New York. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 19 Sep 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/life+science.html"><![CDATA[life science]]></category>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://resources.bnet.com/topic/ubs+ag.html"><![CDATA[UBS AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">UBS</category>
		<category domain="tickers">UBS</category>
	</item>
	<item>
		<title><![CDATA[Media Alert: Check Point Preemptively Protects Against New Pharming Attack]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Sept_19/ai_n27378897]]></link>
		<description><![CDATA[Check Point SmartDefense subscribers immune to BIND DNS server threat]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 19 Sep 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/check+point+software+technologies+ltd..html"><![CDATA[Check Point Software Technologies Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CHKP</category>
		<category domain="tickers">CHKP</category>
	</item>
	<item>
		<title><![CDATA[PHARMING RECIEVES ORPHAN PRODUCT GRANT FROM US FDA FOR RHUCIN(R)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200610/ai_n16767022]]></link>
		<description><![CDATA[Biotech company  Pharming Group NV ("Pharming")  (Euronext: PHARM)  (PHARM.AS) announced  today that it  has received  a grant  from the  US FDA's  Office of  Orphan Products  Development   OPD  for   the  clinical   development...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 06 Oct 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[PHARMING HIGHLIGHTS RESEARCH INNOVATION AND NEW GROWTH ERA AT UBS CONFERENCE]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200609/ai_n16741910]]></link>
		<description><![CDATA[Leiden, The Netherlands, September 25, 2006. Biotech company Pharming Group NV ("Pharming") (Euronext: PHARM) (PHARM.AS) presented today on its value creation  and research  innovation at the  UBS Global  Life Sciences Conference in New York. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 25 Sep 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://resources.bnet.com/topic/ubs+ag.html"><![CDATA[UBS AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">UBS</category>
		<category domain="tickers">UBS</category>
	</item>
	<item>
		<title><![CDATA[PHARMING TO PRESENT AT UBS GLOBAL LIFE SCIENCES CONFERENCE]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200609/ai_n16742646]]></link>
		<description><![CDATA[Leiden,  The  Netherlands,  September  21,  2006.    Biotech  company Pharming Group NV ("Pharming") (Euronext: PHARM) (PHARM.AS) announced today that Dr.  Francis Pinto,  Chief Executive  Officer of  Pharming will present at  the UBS Global  Life Sciences Conference...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 21 Sep 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://resources.bnet.com/topic/ubs+ag.html"><![CDATA[UBS AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">UBS</category>
		<category domain="tickers">UBS</category>
	</item>
	<item>
		<title><![CDATA[PHARMING RECEIVES FAST TRACK DESIGNATION FROM US FDA FOR RECOMBINANT HUMAN C1 INHIBITOR]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200607/ai_n16631552]]></link>
		<description><![CDATA[Leiden, The  Netherlands, July  28,  2006. Biotech  company Pharming Group NV ("Pharming")  (Euronext: PHARM)  (PHARM.AS) announced today that it has received a Fast Track designation on recombinant human C1 inhibitor (rhC1INH) for the treatment of hereditary angioedema HAE from the US Food and Drug...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 28 Jul 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[PHARMING RECIEVES ORPHAN DRUG DESIGNATIONS FOR RHC1INH FROM US FDA]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200606/ai_n16474464]]></link>
		<description><![CDATA[Leiden, The Netherlands,  June 14,  2006.   Biotech company Pharming Group NV ("Pharming"  or "the Company")  (Euronext: PHARM) announced today it has received orphan drug designations for recombinant human C1 inhibitor (rhC1INH) from the  Food and Drug Administration FDA. The Company has  obtained...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 14 Jun 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/designation.html"><![CDATA[designation]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[The Threats of Pharming Unveiled in Mirapoint's Analyst Corner]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_April_19/ai_n26834416]]></link>
		<description><![CDATA[SUNNYVALE, Calif. -- The Radicati Group Examines the Threats of Pharming in the Analyst Corner April Edition]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 19 Apr 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Phishing and Pharming: Understanding Phishing and Pharming]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=177397]]></link>
		<description><![CDATA[Phishing and pharming, along with their associated identity thefts, continue to grow at an alarming rate and are wreaking major havoc on the world's economy, as well as individual financial standings. Because these scams are difficult to detect and the sums of money made by criminal organizations through these activities...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Sun, 01 Jan 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/mcafee+inc..html"><![CDATA[McAfee Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[Pharming]]></category>
		<category domain="http://resources.bnet.com/topic/phishing.html"><![CDATA[Phishing]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[Security]]></category>
		<category domain="http://resources.bnet.com/topic/spam.html"><![CDATA[Spam]]></category>
		<category domain="http://resources.bnet.com/topic/spam+and+phishing.html"><![CDATA[Spam And Phishing]]></category>
		<category domain="http://resources.bnet.com/topic/viruses+and+worms.html"><![CDATA[Viruses And Worms]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MFE</category>
		<category domain="tickers">MFE</category>
	</item>
	<item>
		<title><![CDATA[PHARMING TO PRESENT AT ING HEALTHCARE CONFERENCE]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200512/ai_n15873294]]></link>
		<description><![CDATA[Leiden, The Netherlands, December 1, 2005.  Biotech company  Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that the Company will  present at the 5th Annual  ING European Healthcare Conference (December 6-7, 2005) in London. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 Dec 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[health care]]></category>
		<category domain="http://resources.bnet.com/topic/ing+group.html"><![CDATA[ING Group]]></category>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Teros Reveals Expanded Anti-Fraud Features in Leading Web Application Gateway; New Appliance Detects and Prevents Deep-Linking and Site Scraping, Greatly Reducing the Effectiveness of Phishing and Pharming Attacks]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Sept_19/ai_n15396242]]></link>
		<description><![CDATA[SUNNYVALE, Calif. -- Teros, the global leader in Web application firewalls, today revealed version 5.2 of the Teros 100 and 200 Web Application Gateways, enhanced to protect against online fraud including phishing. New enhancements include expanded anti-fraud features that disrupt multiple stages of the online fraud life cycle. The solution...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 19 Sep 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/gateway+inc..html"><![CDATA[Gateway Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://resources.bnet.com/topic/phishing.html"><![CDATA[phishing]]></category>
		<category domain="http://resources.bnet.com/topic/web.html"><![CDATA[Web]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GTW</category>
		<category domain="tickers">GTW</category>
	</item>
	<item>
		<title><![CDATA[Trading for a high.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4692/is_200508/ai_n17582636]]></link>
		<description><![CDATA[Byline: Carolyn Banta     Aug 03, 2005 (Time Australia - ABIX via COMTEX) -- There is a  growing trend in the US for        teenage drug abusers to use  prescription         ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 03 Aug 2005 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/columbia+university.html"><![CDATA[Columbia University]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Shred reckoning.(UPGRADE: Abusive Lab Test)(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb241/is_200508/ai_n18894738]]></link>
		<description><![CDATA[THE RISE OF INTERNET SCAMS such as phishing and now pharming (see  page 24) has given identity thieves the luxury of working from home, but  a great deal of stolen information still comes from personal documents.  The Federal Trade Commission recommends shredding receipts, credit card  applications,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 01 Aug 2005 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bank.html"><![CDATA[bank]]></category>
		<category domain="http://resources.bnet.com/topic/ftc.html"><![CDATA[FTC]]></category>
		<category domain="http://resources.bnet.com/topic/insurance.html"><![CDATA[insurance]]></category>
		<category domain="http://resources.bnet.com/topic/internet.html"><![CDATA[INTERNET]]></category>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://resources.bnet.com/topic/phishing.html"><![CDATA[Phishing]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[SECURITY]]></category>
	</item>
	<item>
		<title><![CDATA[Pharming: the food industry says genetically modified food is perfectly safe; consumers, environmentalists, and many others aren't so sure. (Food - GM Food).(Statistical Data Included)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb3211/is_200203/ai_n7888085]]></link>
		<description><![CDATA[Traditional plant genetics swaps genes between similar species, so  the process is more like natural selection. Genetic engineering allows  genes from any plant or organism to be inserted into any other plant or  organism, by-passing natural reproductive barriers between species. For  example, fish genes have been...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Mar 2002 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/canada.html"><![CDATA[Canada]]></category>
		<category domain="http://resources.bnet.com/topic/food.html"><![CDATA[food]]></category>
		<category domain="http://resources.bnet.com/topic/general+motors+corp..html"><![CDATA[General Motors Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GMGMQ</category>
		<category domain="tickers">GMGMQ</category>
	</item>
	<item>
		<title><![CDATA[GENZYME Corp.(acquires assets of Pharming NV)(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200111/ai_n13210625]]></link>
		<description><![CDATA[GENZYME Corp. has acquired certain assets of Pharming NV, a  Belgium-based Pharming Group subsidiary operating under a court  supervised receivership, including a 70,000 square foot cGMP protein  manufacturing unit being built, and a transgenic human     GENZYME Corp. has acquired certain assets of Pharming...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 05 Nov 2001 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/asset.html"><![CDATA[asset]]></category>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="tickers">GENZ</category>
	</item>
	<item>
		<title><![CDATA[Pharming Group N.V. Reports Half year Results 2000, Revenues up 75% &#151; Pharming strengthened partnership with Genzyme]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2000_August_1/ai_63777151]]></link>
		<description><![CDATA[Business Editors        LEIDEN, The Netherlands--BUSINESS WIRE--Aug. 1, 2000--Pharming Group N.V. (EASDAQ: PHAR / AEX: PHAR) announced financial interim results for its first half-year ended June 30, 2000.  Financial Highlights  --       Total revenues increased 75% to...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 01 Aug 2000 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/asset.html"><![CDATA[asset]]></category>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/partnership.html"><![CDATA[partnership]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="tickers">GENZ</category>
	</item>
	<item>
		<title><![CDATA[Pharming Healthcare to Open Blacksburg, Va., Dairy Drug Plants.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_199907/ai_n22412009]]></link>
		<description><![CDATA[Knight Ridder/Tribune Business News    Jun. 30 -- RICHMOND, Va. -- A Dutch company that develops human  medicines using animals' milk is coming to Craig County and  Blacksburg, bringing 88 jobs and $37 million in investments with it,  state government officials confirmed Monday.  ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 Jul 1999 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/netherlands.html"><![CDATA[Netherlands]]></category>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://resources.bnet.com/topic/virginia.html"><![CDATA[Virginia]]></category>
		<category domain="http://resources.bnet.com/topic/virginia+tech.html"><![CDATA[Virginia Tech]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Gene Pharming Europe acquires casein promoter patents from Biogen]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_1995_Jan_24/ai_16221883]]></link>
		<description><![CDATA[MOUNTAIN VIEW, Calif.--BUSINESS WIRE--Jan. 24, 1995--GenPharm International's European affiliate, Gene Pharming Europe B.V., (Leiden, The Netherlands) announced Tuesday the acquisition from Biogen Inc. (Cambridge, Mass.) of U.S. patent No. 4,873,316 and corresponding U.S. and international patent filings.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 24 Jan 1995 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biogen+idec+inc..html"><![CDATA[Biogen Idec Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharming.html"><![CDATA[pharming]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
		<category domain="tickers">BIIB</category>
	</item>
</channel>
</rss>
